Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips

被引:34
作者
Antonova, O. V. [1 ,2 ,3 ]
Gryadunov, D. A. [1 ,2 ,3 ]
Lapa, S. A. [1 ,2 ,3 ]
Kuz'min, A. V. [1 ,2 ,3 ]
Larionova, E. E. [1 ,2 ,3 ]
Smirnova, T. G. [1 ,2 ,3 ]
Nosova, E. Yu. [1 ,2 ,3 ]
Skotnikova, O. I. [1 ,2 ,3 ]
Chernousova, L. N. [1 ,2 ,3 ]
Moroz, A. M. [1 ,2 ,3 ]
Zasedatelev, A. S. [1 ,2 ,3 ]
Mikhailovich, V. M. [1 ,2 ,3 ]
机构
[1] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia
[2] Russian Acad Med Sci, Cent Inst TB, Moscow, Russia
[3] Moscow Res & Pract Ctr TB Control, Moscow, Russia
关键词
Mycobacterium tuberculosis; biochip; fluoroquinolones; hybridization; polymerase chain reaction;
D O I
10.1007/s10517-008-0034-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
We developed a method of identification of Mycobacterium tuberculosis with simultaneous evaluation of the sensitivity to fluoroquinolones on a biological microchip array. The method of multiplex two-staged PCR followed by hybridization of a biochip makes it possible to detect 8 mutant variants of gyrA gene occurring in fluoroquinolone-resistant strains (similar to 85% all resistant forms) within 1 day. Using this method we analyzed 107 cultures isolated from patients with tuberculosis and 78 sputum samples. Mutations in gyrA gene were detected in 48 (92%) resistant strains. Natural S95T polymorphism in gyrA gene was detected in all resistant and in 76% sensitive strains. The sensitivity and specificity of the proposed method calculated on the basis of the analysis of sputum samples (n=78) were 94 and 100%, respectively.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 14 条
[1]
CHARACTERIZATION OF FLUOROQUINOLONE-RESISTANT MUTANT STRAINS OF MYCOBACTERIUM-TUBERCULOSIS SELECTED IN THE LABORATORY AND ISOLATED FROM PATIENTS [J].
ALANGADEN, GJ ;
MANAVATHU, EK ;
VAKULENKO, SB ;
ZVONOK, NM ;
LERNER, SA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1700-1703
[2]
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis:: Functional analysis of mutant enzymes [J].
Aubry, A ;
Veziris, N ;
Cambau, E ;
Truffot-Pernot, C ;
Jarlier, V ;
Fisher, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :104-112
[3]
Baldeviano-Vidalón GC, 2005, INT J TUBERC LUNG D, V9, P1155
[4]
Bryskier A, 2002, EXPERT OPIN INV DRUG, V11, P233
[5]
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates [J].
Cheng, AFB ;
Yew, WW ;
Chan, EWC ;
Chin, ML ;
Hui, MMM ;
Chan, RCY .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :596-601
[6]
Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis [J].
Giannoni, F ;
Iona, E ;
Sementilli, F ;
Brunori, L ;
Pardini, M ;
Migliori, GB ;
Orefici, G ;
Fattorini, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2928-2933
[7]
Fluoroquinolones, tuberculosis, and resistance [J].
Ginsburg, AS ;
Grosset, JH ;
Bishai, WR .
LANCET INFECTIOUS DISEASES, 2003, 3 (07) :432-442
[8]
Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis [J].
Gryadunov, D ;
Mikhailovich, V ;
Lapa, S ;
Roudinskii, N ;
Donnikov, M ;
Pan'kov, S ;
Markova, O ;
Kuz'min, A ;
Chernousova, L ;
Skotnikova, O ;
Moroz, A ;
Zasedatelev, A ;
Mirzabekov, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (07) :531-539
[9]
Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria [J].
Guillemin, I ;
Jarlier, V ;
Cambau, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :2084-2088
[10]
Kent P.T., 1985, PUBLIC HLTH MYCOBACT